185 related articles for article (PubMed ID: 34906772)
1. EZH2 as a new therapeutic target in brain tumors: Molecular landscape, therapeutic targeting and future prospects.
Paskeh MDA; Mehrabi A; Gholami MH; Zabolian A; Ranjbar E; Saleki H; Ranjbar A; Hashemi M; Ertas YN; Hushmandi K; Mirzaei S; Ashrafizadeh M; Zarrabi A; Samarghandian S
Biomed Pharmacother; 2022 Feb; 146():112532. PubMed ID: 34906772
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression via Wnt/β-catenin signaling pathway by targeting EZH2.
Xu H; Zhao G; Zhang Y; Jiang H; Wang W; Zhao D; Hong J; Yu H; Qi L
Stem Cell Res Ther; 2019 Dec; 10(1):381. PubMed ID: 31842978
[TBL] [Abstract][Full Text] [Related]
3. Analysis of EZH2: micro-RNA network in low and high grade astrocytic tumors.
Sharma V; Purkait S; Takkar S; Malgulwar PB; Kumar A; Pathak P; Suri V; Sharma MC; Suri A; Kale SS; Kulshreshtha R; Sarkar C
Brain Tumor Pathol; 2016 Apr; 33(2):117-28. PubMed ID: 26746204
[TBL] [Abstract][Full Text] [Related]
4. Functional roles of enhancer of zeste homolog 2 in gliomas.
Yin Y; Qiu S; Peng Y
Gene; 2016 Jan; 576(1 Pt 2):189-94. PubMed ID: 26435191
[TBL] [Abstract][Full Text] [Related]
5. EZH2 as a potential therapeutic target for gastrointestinal cancers.
Hashemi M; Nazdari N; Gholamiyan G; Paskeh MDA; Jafari AM; Nemati F; Khodaei E; Abyari G; Behdadfar N; Raei B; Raesi R; Nabavi N; Hu P; Rashidi M; Taheriazam A; Entezari M
Pathol Res Pract; 2024 Jan; 253():154988. PubMed ID: 38118215
[TBL] [Abstract][Full Text] [Related]
6. EZH2-mediated H3K27me3 enrichment on the lncRNA MEG3 promoter regulates the growth and metastasis of glioma cells by regulating miR-21-3p.
Qin WX; Shi Y; Zhu D; Li YP; Chen YH; Cui J; Cui GY; Pan JX; Ren ZY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3204-3214. PubMed ID: 32271438
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic modification in gliomas: role of the histone methyltransferase EZH2.
Bian EB; Li J; He XJ; Zong G; Jiang T; Li J; Zhao B
Expert Opin Ther Targets; 2014 Oct; 18(10):1197-206. PubMed ID: 25046371
[TBL] [Abstract][Full Text] [Related]
8. The long and short non-coding RNAs modulating EZH2 signaling in cancer.
Mirzaei S; Gholami MH; Hushmandi K; Hashemi F; Zabolian A; Canadas I; Zarrabi A; Nabavi N; Aref AR; Crea F; Wang Y; Ashrafizadeh M; Kumar AP
J Hematol Oncol; 2022 Mar; 15(1):18. PubMed ID: 35236381
[TBL] [Abstract][Full Text] [Related]
9. Effects of Enhancer of Zeste Homolog 2 (EZH2) Expression on Brain Glioma Cell Proliferation and Tumorigenesis.
Cheng T; Xu Y
Med Sci Monit; 2018 Oct; 24():7249-7255. PubMed ID: 30305602
[TBL] [Abstract][Full Text] [Related]
10. EZH2 regulates the malignancy of human glioblastoma cells via modulation of Twist mRNA stability.
Zhai X; Li LS; Zhou YD; Ji WY; Chen H; Xiao H; Liang P
Eur J Pharmacol; 2021 Aug; 904():174177. PubMed ID: 34015321
[TBL] [Abstract][Full Text] [Related]
11. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
Zou S; Gao Y; Zhang S
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
[TBL] [Abstract][Full Text] [Related]
12. EZH2 is a potential prognostic predictor of glioma.
Chen YN; Hou SQ; Jiang R; Sun JL; Cheng CD; Qian ZR
J Cell Mol Med; 2021 Jan; 25(2):925-936. PubMed ID: 33277782
[TBL] [Abstract][Full Text] [Related]
13. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.
Zhang Y; Wang J; An W; Chen C; Wang W; Zhu C; Chen F; Chen H; Zheng W; Gong J
Technol Cancer Res Treat; 2019; 18():1533033819854132. PubMed ID: 31138033
[TBL] [Abstract][Full Text] [Related]
14. Ribosomal S6 protein kinase 4 promotes resistance to EZH2 inhibitors in glioblastoma.
Pang F; Zhang L; Li M; Yi X; Wang Y; Yang P; Wen B; Jiang J; Teng Y; Yang X; Chen L; Xu J; Wang L
Cancer Gene Ther; 2023 Dec; 30(12):1636-1648. PubMed ID: 37726387
[TBL] [Abstract][Full Text] [Related]
15. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
16. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
Xu C; He T; Li Z; Liu H; Ding B
Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
[TBL] [Abstract][Full Text] [Related]
17. lncRNA TUG1 inhibits the cancer stem cell‑like properties of temozolomide‑resistant glioma cells by interacting with EZH2.
Cao Y; Chai W; Wang Y; Tang D; Shao D; Song H; Long J
Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 34036375
[TBL] [Abstract][Full Text] [Related]
18. Polycomb complex mediated epigenetic reprogramming alters TGF-β signaling via a novel EZH2/miR-490/TGIF2 axis thereby inducing migration and EMT potential in glioblastomas.
Vinchure OS; Sharma V; Tabasum S; Ghosh S; Singh RP; Sarkar C; Kulshreshtha R
Int J Cancer; 2019 Sep; 145(5):1254-1269. PubMed ID: 31008529
[TBL] [Abstract][Full Text] [Related]
19. EZH2 in Cancer Progression and Potential Application in Cancer Therapy: A Friend or Foe?
Yan KS; Lin CY; Liao TW; Peng CM; Lee SC; Liu YJ; Chan WP; Chou RH
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28561778
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
